IN THE NAME OF GOD CASE PRESENTATION BY: Dr.Isa Khaheshi

Slides:



Advertisements
Similar presentations
1 Welcome to Case Discussion
Advertisements

EP Testing and Use of Devices in Heart Failure HFSA 2010 Recommendations.
DR. MOHAMMED AL-MARWALH DR. ABEER ALSALABA DR. AREEJ AL-JABALI DR.RWA'A YASSEN DR.ABDULAZIZ AONALLAH DCMP complicated by LV thrombus.
PULMONARY GRAND ROUNDS Eduardo Santiago March 08,2012.
Auscultation.
VSD Case Discussion. Patient Data 23 y/o female 23 y/o female Underline Disease: Underline Disease: 1. Large VSD 2. Pulmonary hypertension, secondary.
Pulmonary Edema.
Practical Diagnoses Using the Cardiolert System Cardiolert Systems copyright 2007 C ardiolert S ystems.
From Cambridge to Cambodia: Experience with a telemedicine project in the developing world Joseph C. Kvedar, MD Director, Partners Telemedicine Vice Chair,
Congestive heart failure
Case present By Intern 劉一璋. Patient data Name: 陳 ○ 富 Sex: 男 Age: 71 歲 Date of admission: 96/08/09 Chart No:
A 68-yr-old man with necrotic lung nodules 6 yrs ago. Permanant pacemaker insertion d/t 3rd degree AV block 4 yrs ago. DOE/ascities/PND/orthopnea 로 지방대.
HEART FAILURE “pump failure”. DEFINITION Heart failure is the inability of the heart to supply adequate blood flow and therefore oxygen delivery.
Some Essentials of Valvular Heart Disease CCU lecture series.
Nicole Rollins.  68 y/o man was referred to cardiology in 2007 for worsening DOE and fatigue  Echocardiogram showed decreased systolic function, EF.
Case - 84 year old woman Main symptoms – Acute dyspnea since 2 weeks, some coughing, yellow sputum Past medical history – Chronic obstructive lung disease.
By: Kyra Alexander.  Heart Failure is a condition in which the heart cannot pump enough blood into the rest of the body.  Often a long-term (Chronic)
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
Heart Failure, HF CHF develops when plasma volume increases and fluid accumulates in the lungs, abdominal organs (liver especially), and peripheral tissues.
CARDIAC ARRHYTHMIA Charn Sriratanasathavorn, MD,FACC
Curtis Nordstrom, M.S. MS-3/6 – Medical University of Sofia Sofia, Bulgaria.
Aetiology * MVP { Myxomatous mv },commonest in developed world *Damage to the cusps : _RVD _ IE _ Congenital Cleft MV *Damage to chordae : _RVD.
STICH Mitral Regurgitation Subanalysis Objective Examine the relationship of mitral regurgitation (MR) severity and survival and compare outcomes in patients.
Following the Outpatient with Severe Mitral Regurgitation Marilyn Weigner MD RIACC 9/02.
Supporting Patients with CHF Care Transformation Collaborative of R.I. MAUREEN CLAFLIN, MSN, RN. NCM UNIVERSITY MEDICINE GOVERNOR STREET PRIMARY CARE CENTER.
Mitral Valve Disease Prof JD Marx UFS January 2006.
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
Acute Renal Failure Cases. Case 1- HPI 71 yo mw/ fever and dysuria for 2 days Decreased UOP but increased frequency Yesterday vomited 3-4 times and developed.
Paediatric and Adult Congenital Cardiology Centre IRCCS, San Donato Hospital, Milan Paediatric and Adult Congenital Cardiology Centre IRCCS, San Donato.
Adi Kartolo University of Ottawa. Initial Presentation 42-year-old African-American male with type 2 diabetes Chief Complaint: increasing body weight.
Interesting Case Presentation Neuroendocrine Lung Tumors M. Demiri B Oncology Clinic Director Saint Savvas Anticancer Hospital.
OSCE Raika Jamali M.D. Gastroenterologist and hepatologist Sina hospital Tehran University of Medical Sciences.
DIFFERENTIATE: 1. HIGH AND LOW OUTPUT FAILURE RIGHT AND LEFT SIDED HEART FAILURE SYSTOLIC FROM DIASTOLIC DYSFUNCTION Question 9.
High-Risk/End-stage Patient With Functional MR: Should We Treat with Anything? Steven R. DeBeer, MD Cardiothoracic Surgery Fellow Emory University AATS.
CLINICAL CONFERENCE By Faizul Haque Date Presented: 12/4/2007 Department of Cardiology University of Illinois at Chicago By Faizul Haque Date Presented:
Zhongshan Hospital, Fudan University Shanghai Cardiovascular Disease Institut Shanghai Cardiovascular Disease Institute Guan Lihua, Zhou Daxin, Ge Junbo.
The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT Systolic Heart failure.
In the name of god.
Which tool do you most typically use to evaluate stroke risk for patients with a fib? 1. CHADS2 score 2. CHADS2-VASc 3. Other 10.
Heart rate in heart failure: Heart rate in heart failure: risk marker or risk factor? A subanalysis of the SHIFT trial on behalf of the Investigators M.
LEARNING OBJECTIVES Consider nonischemic causes of ventricular arrhythmia Add cardiac sarcoid to your differential diagnosis for ventricular arrhythmia.
Internal Medicine Workshop Series Laos September /October 2009
Heart Failure. Objectives Identify the differences between Heart Attack and Heart Failure. List three symptoms of Heart Failure. Name three types of Heart.
Definition: the backward flow of blood into the LA during systole. *Read pages 10 – 17in The Echocardiographer’s Pocket Reference; Read pages 292 – 304.
CONGESTIVE HEART FAILURE Definition: Heart failure occurs when the output from the heart is no longer able to meet the body's metabolic demands for oxygen.
Biomarkers that “guide” therapy
Valve Replacement Surgery
Non Wilsonian Hepatocerebral Degeneration
Atrial Fibrillation in a CLL Patient Treated with Ibrutinib
EPIC 2012 Live Case Presentation
Morning Report Anne Lachiewicz April 5, 2010.
Amin Jahanbakhshi M.D. , Guive Sharifi M.D. , Kaveh Ebrahim Zadeh M.D.
Case studies December 2007 C.M.R.I..
Heart Failure - Summary
Drug Induced Ductopenia
Aortic Valve Treatment in Extensive Ascending Aortic Calcification
AFP > 9000 without demonstrable HCC
Systolic Heart failure treatment with the If inhibitor ivabradine Trial The effect of heart rate reduction with ivabradine on renal function in patients.
دانشگاه شهیدرجایی تهران
Giant Hemangiomas.
Brans-Dicke DGP brane cosmology
تعهدات مشتری در کنوانسیون بیع بین المللی
Expert Insights on Complex Clinical Cases of Edema
دومین کمیته مترجمین حاکمیت بالینی دانشگاه
Shahid Beheshti University of Medical Sciences
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Time to first event analysis revealed a significant difference in estimated event-free (death or hospitalisation) survival between patients with left ventricular.
Case studies December 2007 C.M.R.I..
Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation: a propensity score matched analysis Maurizio Taramasso MD, PhD from.
Presentation transcript:

IN THE NAME OF GOD CASE PRESENTATION BY: Dr.Isa Khaheshi Cardiovascular Research Center, Modarres Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

41 y/o woman presented with h/x of ascites , fatigue and mild lower limbs edema from several months ago whom was undergone medical treatment with Lasix,Aldactone,Digoxine,lisinopril PMH:h/x of MVR 12 years ago due to severe MR RF:-

PH/X: Heart: S1,S2 irregular rhythm Lungs: clear, no rales Abdomen: soft, no organomegally,no significant shifting dullness Extremities: no edema

Ultrasonography of abdomen: *Ascites , *Liver congestion due to right side HF

TTE,TEE: EF=60%, MODERATE RVE,MODERATE RV SYSTOLIC DYSFUNCTION, NON-CAOPTED TV LEAFLETS WITH SEVERE TR,PAP=30,TV ANULUS=39 MM WELL SEATED MECHANICAL MV (MPG=2.6,PPG=17.6,PHT=80)

What is your decision about severe TR????

Thanks a lot for your attention